November 25, 2022 - Meeting with Aram Mangasarian, CEO of TME Pharma

Описание к видео November 25, 2022 - Meeting with Aram Mangasarian, CEO of TME Pharma

Aram Mangasarian presents key highlights of recently reported data from the GLORIA Phase 1/2 study in brain cancer, focusing on exciting data in the NOXA12 + RT + bevacizumab arm.

Комментарии

Информация по комментариям в разработке